Shrinking Optics. Unlocking Possibilities

GET CONNECTED
leadoptik.com

Team

Reza Khorasaninejad

CEO & Founder

Leadoptik

Company details

LEADOPTIK is pioneering an integrated imaging biopsy needle specifically designed for the detection and diagnosis of early-stage peripheral lung cancer.

Deep Tech 100Human HealthUnited StatesSeries A(+)DiagnosticsHard TechHealthcareHuman HealthHAX 2020

Company News

Leadoptik and Stanford Medicine to explore imaging in lung biopsy procedures

March 20, 2025
Yahoo Finance

Leadoptik Receives Investment from Applied Ventures – FinSMEs

June 20, 2023
FinSMEs

LEADOPTIK: $5 Million Secured To Build Early Lung Cancer Detection – Pulse 2.0

June 8, 2023
Pulse 2.0

Get In Touch with Leadoptik

Please tell us a little bit about yourself and why you'd like to get connected. Leadoptik + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More